Cite
HARVARD Citation
Papp, K. et al. (2019). Ixekizumab—An Effective and Safe Treatment for Moderate-to-Severe Plaque Psoriasis in Patients Previously Treated With Other IL-17 Inhibitors: Results From IXORA-P. Journal of psoriasis and psoriatic arthritis. 4 (4), pp. 180-185. [Online].